Patents by Inventor Miguel A. Vega

Miguel A. Vega has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20140094301
    Abstract: A gaming machine has a cabinet with a cabinet frame, a display device, a light source, and a directional transmissible layer with directional light planes arranged parallel to and offset from each other. The display device is located within the cabinet frame and is configured to display a wagering game. The light source is positioned above the display device, within the cabinet frame, and emits direct light and indirect light towards a player position in front of the gaming machine. The indirect light reflects off the display device prior to reaching the player position, causing light glare towards the player position. To reduce or eliminate the light glare, the directional transmissible layer is placed at least in part over the light source such that the directional light planes are horizontally aligned with the display device to prevent at least some of the indirect light from reflecting off the display device.
    Type: Application
    Filed: March 7, 2013
    Publication date: April 3, 2014
    Applicant: WMS GAMING INC.
    Inventors: Bradley D. Cornell, Timothy C. Loose, Scott A. Massing, Miguel A. Vega
  • Publication number: 20130160161
    Abstract: The invention provides compositions and methods for inhibiting the expression of the gene Snl6 in plants. Plants with inhibited expression of Snl6 have use in biofuel production, e.g., by increasing the amount of soluble sugar that can be extracted from the plant.
    Type: Application
    Filed: June 17, 2011
    Publication date: June 20, 2013
    Applicant: The Regents of the University of California
    Inventors: Rebecca Bart, Mawsheng Chern, Pamela Ronald, Miguel Vega-Sanchez
  • Publication number: 20120220353
    Abstract: Gaming terminals, gaming machines, gaming systems, and methods of reconfiguring a display device are presented herein. A gaming terminal for playing a wagering game is disclosed, which includes an input device configured to receive a wager to play the wagering game, a cabinet, and a display device operatively mounted to the cabinet. The display device has an electronic graphical display screen that is operable to dynamically display information related to the wagering game. The display screen is configured to physically change shape and/or size.
    Type: Application
    Filed: February 24, 2012
    Publication date: August 30, 2012
    Applicant: WMS Gaming Inc.
    Inventors: Scott A. Massing, Frank E. Rodriguez, Timothy C. Loose, James M. Rasmussen, Kenneth M. Ross, Miguel A. Vega
  • Publication number: 20110014975
    Abstract: A gaming system comprises a wager input device for receiving at least one wager and a display for displaying a wagering game. The display includes an integrated image capture device for visually capturing objects proximate the display. The system further comprises at least one controller operative to (i) detect the presence of at least a first object proximate the display, (ii) cause the image capture device to visually capture the first object and create a stored image thereof, (iii) graphically integrate the stored image of the first object into the wagering game, and (iv) display one or more outcomes of the wagering game which include one or more symbols comprising at least a portion of the stored image.
    Type: Application
    Filed: February 19, 2009
    Publication date: January 20, 2011
    Applicant: WMS Gaming Inc.
    Inventors: Jacek Grabiec, Jeremy M. Hornik, Joel R. Jaffe, Timothy C. Loose, Larry J. Pacey, Miguel A. Vega, Muthu Velu
  • Publication number: 20040259818
    Abstract: The quaternary ammonium N-glucuronide adduct of 7-(1,1-dimethylethyl)-6-(2-ethyl-2H-1,2,4-triazol-3-yl-methoxy)-3-(2-fluorophenyl)-1,2,4-triazolo[4,3-b]pyridazine is cleavable by glucuronidase enzymes in the body and can thereby act as a prodrug of a therapeutic agent which is a selective ligand for GABAA receptors, in particular having high affinity for the &agr;2 and/or &agr;3 subunit thereof, and is accordingly of benefit in the treatment and/or prevention of disorders of the central nervous system, including anxiety and convulsions.
    Type: Application
    Filed: July 26, 2004
    Publication date: December 23, 2004
    Inventors: Byron Halevy, Matthew Paul, Donghui Cui, Stacey Lynn Polsky, A. David Rodrigues, Jose Miguel Vega, Stanley Vickers